TQCAX
Price
$20.21
Change
+$0.11 (+0.55%)
Updated
Sep 26 closing price
Net Assets
2.39B
VIVAX
Price
$72.78
Change
+$0.60 (+0.83%)
Updated
Sep 26 closing price
Net Assets
202.84B
Interact to see
Advertisement

TQCAX vs VIVAX

Header iconTQCAX vs VIVAX Comparison
Open Charts TQCAX vs VIVAXBanner chart's image
Touchstone Dividend Equity A
Price$20.21
Change+$0.11 (+0.55%)
VolumeN/A
Net Assets2.39B
Vanguard Value Index I
Price$72.78
Change+$0.60 (+0.83%)
VolumeN/A
Net Assets202.84B
TQCAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TQCAX vs. VIVAX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TQCAX is a Hold and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. TQCAX (2.39B). VIVAX pays higher dividends than TQCAX: VIVAX (1.99) vs TQCAX (1.44). TQCAX was incepted earlier than VIVAX: TQCAX (27 years) vs VIVAX (33 years). TQCAX (1.01) is less costly to investors than VIVAX (0.17). TQCAX is a more actively managed with annual turnover of: 37.00 vs. VIVAX (9.00). TQCAX has a lower initial minimum investment than VIVAX: TQCAX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 7.64 vs. TQCAX (5.48). VIVAX return over 5 years is better than : 81.78 vs. TQCAX (53.68).
TQCAXVIVAXTQCAX / VIVAX
Total Expense Ratio0.990.17582%
Annual Report Gross Expense Ratio1.010.17594%
Fund Existence27 years33 years-
Gain YTD13.11210.222128%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.39B203B1%
Annual Yield % from dividends1.441.9972%
Returns for 1 year5.487.6472%
Returns for 3 years42.2450.2284%
Returns for 5 years53.6881.7866%
Returns for 10 years59.19147.6840%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDHL1.840.19
+11.52%
Redhill Biopharma Ltd
IRON65.553.05
+4.88%
Disc Medicine
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
ASTS49.09-0.30
-0.61%
AST SpaceMobile
AMTD1.17-0.03
-2.89%
AMTD IDEA Group